Submitted by Anonymous (not verified) on 5 September 2023 - 11:20
Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Ovarian Neoplasms;Sarcoma, Kaposi;Multiple Myeloma, Date of authorisation: 31/05/2022, Revision: 2, Status: Authorised
Source: